ANALYSIS OF DRUG PRODUCTS ASSORTMENT ACQUIRABLE BY HEALTHCARE ORGANIZATIONS FOR MEDICAL TREATMENT IN HOSPITAL SETTINGS WAS CONDUCTED
Abstract
analysis of drug products assortment acquirable by healthcare organizations for medical treatment in hospital settings was conducted. Numerous violations of active law were detected and creation of drug assistance medical care standards was suggested as a financial spending optimization tool based on acquisition of drug products with proven clinical efficiency and minimal treatment cycle cost.
About the Author
M. G. MalaevRussian Federation
MD, an independent expert, auditor, consultant (Moscow, Russia)
References
1. Malaev M.G. Kachestvennaya klinicheskaya praktika. 2013; 3: 43-51.
2. Resolution of the Government of the Russian Federation dated 18.10.2013 № 932 «About the state guarantees the provision of free medical care to citizens in 2014 and the planning period in 2015 and 2016.» [Postanovlenie Pravitel'stva Rossiiskoi Federatsii ot 18.10.2013 №932 «O programme gosudarstvennykh garantii besplatnogo okazaniya grazhdanam meditsinskoi pomoshchi na 2014 god i na planovyi period 2015 i 2016 godov»].
3. Federal Law of 27.12.2002 N 184-FZ «On Technical Regulation» (as amended on 28.12.2013) [Federal'nyi zakon ot 27.12.2002 N 184- FZ «O tekhnicheskom regulirovanii» (red. ot 28.12.2013)].
4. Federal Law of 21.11. 2011 N 323-FZ «On the basis of health protection in the Russian Federation» [Federal'nyi zakon ot 21.11. 2011 N 323-FZ «Ob osnovakh okhrany zdorov'ya grazhdan v Rossiiskoi Federatsii»].
For citation:
Malaev M.G. ANALYSIS OF DRUG PRODUCTS ASSORTMENT ACQUIRABLE BY HEALTHCARE ORGANIZATIONS FOR MEDICAL TREATMENT IN HOSPITAL SETTINGS WAS CONDUCTED. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2014;7(2):44-50. (In Russ.)
Views: 481
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 